FacebookTwitterGoogle+RedditEmail

Merck’s Merry Christmas

by CHRISTOPHER BRAUCHLI

For all three groups Christmas came early. For the first group it came in September. For the second group it came in mid-December and for the third group, which got the best present, it came at the end of November. All the gifts came from Merck & Co.

On September 30 folks who had suffered from arthritic joints that were being helped by Merck’s Vioxx learned that although the joints might feel better their hearts might not share in the relief. On that date it was revealed that the FDA had issued a statement in which it said that people taking Vioxx: “face twice the risk of a heart attack compared to patients receiving a placebo.” Those with sore joints probably did not relish the thought of relieving joint pain at the risk of dying of a heart attack. It hardly seemed like a reasonable quid pro quo. Although I am not a scientist and hence unable to judge who is right and who is wrong, there are those in the scientific community who believe that Merck knew or could have known, had it chosen to look, that the drug posed a considerable risk to its users.

According to one group of Swiss scientists, Merck should have known of the problem as early as 2000. The group at the University of Berne analyzed the results of 18 “randomized clinical trials” and 11 “observational studies.” The scientists, conclusions were that a decision to remove the drug from the market place should have come three years before the decision was in fact reached. The scientists said that Merck’s own study called “Vigor” demonstrated that people taking Vioxx had a five times greater chance of having a heart attack than similar patients on another anti-inflammatory drug also being used to alleviate the suffering of those afflicted with arthritis. The Swiss scientists were not the only researchers who questioned Merck’s conduct with respect to that drug.

On December 2, 1999 the doctor who headed the Vigor trial for Merck wrote a memorandum in which he said Vioxx patients were suffering twice as many events of death or “serious cardiovascular” problems as patients using naproxen. Whether Merck knew or should have known others will decide as time goes on. What everyone knows is it was an early Christmas present of the unpleasant sort for those who had been taking the drug.

An equally unpleasant Christmas present was delivered to 700 Merck employees exactly 10 days before Christmas. They were told that they would be losing their jobs before year end. In doing so, they were joining the 4,400 other Merck employees who had already been told their jobs would disappear. The 700 persons who were losing their jobs were being fired because of the adverse effect news of Vioxx’s removal from the market place had on the company’s earnings. As unpleasant as all that news was for customers and low level employees, there was one group of people associated with Merck for whom the Christmas season promised to be a lot more cheerful. Those were the highly paid executives at the company.

One of the risks attendant upon disclosures such as those made about Vioxx, is that the company manufacturing the tainted drug may be taken over by another company. When that happens there is always a chance that the top level employees will find themselves jobless which is, understandably, distressing to the affected employees. In an attempt to protect top level employees from such untoward effects and in order to give them the peace of mind everyone wants during the holidays, the Board of Directors of Merck did a very courageous thing, even knowing that people like me would probably be critical since the company’s stock has dropped by 70 percent since 2000 and suffered a $25 billion loss in market value following the Vioxx withdrawal announcement on September 30.

On November 30 it said, in so many words, that it was doing something to guarantee its top 230 managers a peaceful holiday season. If another company buys all of Merck or as little as 20 percent of its stock, those managers will each get between 1.5 and 3 years salary plus a bonus. That would warm anyone’s hearth and heart during Christmas and that’s not all. If following a takeover, one of the 230 gets fired or resigns for good cause, the payment will be made. No one knows how much that will cost the company but some analysts say it will be in the hundreds of millions of dollars.

Anita Larsen is a Merck spokeswoman. She says this has nothing to do with Vioxx problems. The board had been considering this plan long before September 30. That might be. Only a really clever group of corporate types would announce it after September 30 and shortly before announcing that the company was spoiling Christmas for an additional 700 employees. Welcome to the world of corporate America and a happy new year.

CHRISTOPHER BRAUCHLI is a lawyer living in Colorado. His column is syndicated by Knight-Ridder. He can be reached at: Brauchli.56@post.harvard.edu

 

More articles by:

CounterPunch Magazine

minimag-edit

Weekend Edition
August 26, 2016
Friday - Sunday
Andrew Stewart
Did Gore Throw the 2000 Election?
William Hughes
From Sam Spade to the Red Scare: Dashiell Hammett’s War Against Rightwing Creeps
Raouf Halaby
Dear Barack Obama, Please Keep it at 3 for 3
Charles R. Larson
Review: Paulina Chiziane’s “The First Wife: a Tale of Polygamy”
August 25, 2016
Mike Whitney
The Broken Chessboard: Brzezinski Gives Up on Empire
Paul Cox – Stan Cox
The Louisiana Catastrophe Proves the Need for Universal, Single-Payer Disaster Insurance
John W. Whitehead
Another Brick in the Wall: Children of the American Police State
Lewis Evans
Genocide in Plain Sight: Shooting Bushmen From Helicopters in Botswana
Daniel Kovalik
Colombia: Peace in the Shadow of the Death Squads
Sam Husseini
How the Washington Post Sells the Politics of Fear
Ramzy Baroud
Punishing the Messenger: Israel’s War on NGOs Takes a Worrying Turn
Norman Pollack
Troglodyte Vs. Goebbelean Fascism: The 2016 Presidential Race
Simon Wood
Where are the Child Victims of the West?
Roseangela Hartford
The Hidden Homeless Population
Mark Weisbrot
Obama’s Campaign for TPP Could Drag Down the Democrats
Rick Sterling
Clintonites Prepare for War on Syria
Yves Engler
The Anti-Semitism Smear Against Canadian Greens
August 24, 2016
John Pilger
Provoking Nuclear War by Media
Jonathan Cook
The Birth of Agro-Resistance in Palestine
Eric Draitser
Ajamu Baraka, “Uncle Tom,” and the Pathology of White Liberal Racism
Jack Rasmus
Greek Debt and the New Financial Imperialism
Robert Fisk
The Sultan’s Hit List Grows, as Turkey Prepares to Enter Syria
Abubakar N. Kasim
What Did the Olympics Really Do for Humanity?
Renee Parsons
Obamacare Supporters Oppose ColoradoCare
Alycee Lane
The Trump Campaign: a White Revolt Against ‘Neoliberal Multiculturalism’
Edward Hunt
Maintaining U.S. Dominance in the Pacific
George Wuerthner
The Big Fish Kill on the Yellowstone
Jesse Jackson
Democrats Shouldn’t Get a Blank Check From Black Voters
Kent Paterson
Saving Southern New Mexico from the Next Big Flood
Arnold August
RIP Jean-Guy Allard: A Model for Progressive Journalists Working in the Capitalist System
August 23, 2016
Diana Johnstone
Hillary and the Glass Ceilings Illusion
Bill Quigley
Race and Class Gap Widening: Katrina Pain Index 2016 by the Numbers
Ted Rall
Trump vs. Clinton: It’s All About the Debates
Eoin Higgins
Will Progressive Democrats Ever Support a Third Party Candidate?
Kenneth J. Saltman
Wall Street’s Latest Public Sector Rip-Off: Five Myths About Pay for Success
Binoy Kampmark
Labouring Hours: Sweden’s Six-Hour Working Day
John Feffer
The Globalization of Trump
Gwendolyn Mink – Felicia Kornbluh
Time to End “Welfare as We Know It”
Medea Benjamin
Congress Must Take Action to Block Weapon Sales to Saudi Arabia
Halyna Mokrushyna
Political Writer, Daughter of Ukrainian Dissident, Detained and Charged in Ukraine
Manuel E. Yepe
Tourism and Religion Go Hand-in-Hand in the Caribbean
ED ADELMAN
Belted by Trump
Thomas Knapp
War: The Islamic State and Western Politicians Against the Rest of Us
Nauman Sadiq
Shifting Alliances: Turkey, Russia and the Kurds
Rivera Sun
Active Peace: Restoring Relationships While Making Change
FacebookTwitterGoogle+RedditEmail